Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne C Li

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Rheumatology Online Journal|August 9, 2017
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician surveyClara Westwell-Roper, Joanna M Lubieniecka, Kelly L Brown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2018
The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic DiseasesSarah Ringold, Peter A Nigrovic, Brian M Feldman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic SclerosisAnne M Stevens, Sami B Kanaan, Kathryn S Torok, et al.
The Journal of Rheumatology|September 17, 2018
New Features for Measuring Disease Activity in Pediatric Localized SclerodermaSuzanne C Li, Xiaohu Li, Elena Pope, et al.
The Journal of Rheumatology|October 17, 2019
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized SclerodermaSuzanne C Li, Kathryn S Torok, C Egla Rabinovich, et al.
Arthritis Care & Research|December 27, 2023
Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity ScaleSuzanne C Li, C Egla Rabinovich, Mara L Becker, et al.
Pediatric Rheumatology Online Journal|July 17, 2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot studySuzanne C Li, Robert C Fuhlbrigge, Ronald M Laxer, et al.
Expert Review of Clinical Immunology|December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Pediatric Rheumatology Online Journal|April 25, 2023
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectivesLeigh A Stubbs, Andrew M Ferry, Danielle Guffey, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Rheumatology Online Journal|August 9, 2017
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician surveyClara Westwell-Roper, Joanna M Lubieniecka, Kelly L Brown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2018
The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic DiseasesSarah Ringold, Peter A Nigrovic, Brian M Feldman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic SclerosisAnne M Stevens, Sami B Kanaan, Kathryn S Torok, et al.
The Journal of Rheumatology|September 17, 2018
New Features for Measuring Disease Activity in Pediatric Localized SclerodermaSuzanne C Li, Xiaohu Li, Elena Pope, et al.
The Journal of Rheumatology|October 17, 2019
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized SclerodermaSuzanne C Li, Kathryn S Torok, C Egla Rabinovich, et al.
Arthritis Care & Research|December 27, 2023
Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity ScaleSuzanne C Li, C Egla Rabinovich, Mara L Becker, et al.
Pediatric Rheumatology Online Journal|July 17, 2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot studySuzanne C Li, Robert C Fuhlbrigge, Ronald M Laxer, et al.
Expert Review of Clinical Immunology|December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Pediatric Rheumatology Online Journal|April 25, 2023
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectivesLeigh A Stubbs, Andrew M Ferry, Danielle Guffey, et al.
Pageof 5